[The efficacy of antibacterial treatment in chronic gastritis of Helicobacter etiology].
A study of 140 patients with chronic gastritis revealed Helicobacter pylori in the gastric antral mucosa in 100% and in the duodenum in 50%. There is a direct correlation between the presence and amount of Helicobacter pylori in the mucosa, lymphoplasmocytic infiltration, dystrophic changes of epithelium. Ampiox treatment proved beneficial both clinically and morphologically. After treatment Helicobacter pylori was absent in 65.7%, in the remaining cases it reduced by 5-10 times.
Medvedev
V N
VN
Knyshov
Iu F
IuF
Orlovskiĭ
V F
VF
D000667:Ampicillin / Q000627:therapeutic use*; D001706:Biopsy; D002908:Chronic Disease; D004341:Drug Evaluation; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005753:Gastric Mucosa / Q000382:microbiology / Q000473:pathology; D005756:Gastritis / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D016480:Helicobacter pylori / Q000302:isolation & purification; D006801:Humans; D010068:Oxacillin / Q000627:therapeutic use*; D011706:Pyloric Antrum
D000667:Ampicillin; C000307:broadcillin; D010068:Oxacillin
Effektivnost' antibakterial'nogo lecheniia pri khronicheskom gastrite khelikobakternoĭ étiologii.